Literature DB >> 6455926

Cutaneous inflammation caused by inadvertent intradermal administration of DTP instead of PPD.

D R Graham, B B Dan, P Bertagnoll, R E Dixon.   

Abstract

In 1979, 101 adults were skin-tested by a health department to evaluate tuberculin reactivity; of the 96 persons followed, 87 (91 per cent) experienced inflammation marked by swelling, erythema, arm pain, and fever. Five months later, a 5 mm to 10 mm purple macule persisted in 76 persons. The vials of PPD reportedly used for testing had been discarded, but PPD had been stored in the refrigerator with DT and DTP. The mean tetanus antitoxin titer in skin-tested persons was 0.14 units per ml (u/ml) vs 0.08 u/ml in untested control persons (p lesser than 0.03). The mean diphtheria antitoxin titer in skin-tested people was 0.90 u/ml vs 0.16 for controls (p = 10(-5)). The mean pertussis antibody in skin-tested persons was 1:169 vs 1:12 for controls (p = 10(-5)). Intradermal DTP in immune rabbits produced histologically typical Arthus reactions similar to those experienced by the humans. Seven months later, 90 persons received PPD injections. Ten had induration; none experienced persistent reactions. We concluded that the humans initially received DTP instead of PPD.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6455926      PMCID: PMC1619857          DOI: 10.2105/ajph.71.9.1040

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  11 in total

1.  Adult immunization. Preparation and evaluation of combined fluid tetanus and diphtheria toxoids for adult use.

Authors:  L LEVINE; J IPSEN; J A MCCOMB
Journal:  Am J Hyg       Date:  1961-01

2.  Determination of diphtheria and tetanus antitoxin by the hemagglutination test in comparison with tests in vivo.

Authors:  J H SCHUBERT; R G CORNELL
Journal:  J Lab Clin Med       Date:  1958-11

3.  Combined tetanus-diphtheria immunization of adults: use of small doses of diphtheria toxoid.

Authors:  G EDSALL; J S ALTMAN; A J GASPAR
Journal:  Am J Public Health Nations Health       Date:  1954-12

4.  Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine.

Authors:  J G Borghans; J L Stanford
Journal:  Am Rev Respir Dis       Date:  1973-01

5.  The specificity of the immediate reaction in tuberculin skin testing with PPD in humans.

Authors:  T Matsumura; T Kuroume; H Tsukagoshi
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

6.  The effect of an exorbitant intracutaneous dose of 200 micrograms PPD tuberculin compared with 0.02 micrograms PPD tuberculin.

Authors:  T Egsmose
Journal:  Am Rev Respir Dis       Date:  1970-07

7.  The pathogenesis of fever in tuberculin hypersensitivity.

Authors:  I V Allen
Journal:  Tubercle       Date:  1965-12

8.  Immediate hypersensitivity to tuberculin. In vivo and in vitro studies.

Authors:  S M Tarlo; J H Day; P Mann; M P Day
Journal:  Chest       Date:  1977-01       Impact factor: 9.410

9.  Use of pertussis vaccine in an epidemic involving hospital staff.

Authors:  C C Linnemann; N Ramundo; P H Perlstein; S D Minton; G S Englender
Journal:  Lancet       Date:  1975-09-20       Impact factor: 79.321

10.  Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants.

Authors:  N R Butler; M A Voyce; W L Burland; M L Hilton
Journal:  Br Med J       Date:  1969-03-15
View more
  3 in total

1.  Advice on administering vaccines.

Authors:  D L Murray
Journal:  Am J Public Health       Date:  1982-01       Impact factor: 9.308

2.  Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting Systems.

Authors:  Soju Chang; Vitali Pool; Kathryn O'Connell; Jacquelyn A Polder; John Iskander; Colleen Sweeney; Robert Ball; M Miles Braun
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Data mining in the US using the Vaccine Adverse Event Reporting System.

Authors:  John Iskander; Vitali Pool; Weigong Zhou; Roseanne English-Bullard
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.